Microarray technology encompasses a few relatively well-established methods and numerous applications that are in various stages of development. Apart from their use as a tool for diagnostic testing ...

Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical studies at a biomedical facility in ...

A carefully thought out method of harvesting and arraying tissue samples into blocks provides a simple but powerful way of reliably producing extremely large tissue microarrays using commonly ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...

A newly developed artificial intelligence (AI) model is highly accurate in predicting blood loss in patients undergoing high-volume liposuction, reports a study in the January issue of Plastic and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...